SLXN
Silexion Therapeutics Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$0.35
+0.06%Leverage
- Debt / equity
- 32.05x
- Net debt / equity
- -18.61x
- Debt / assets
- 0.33x
- Debt / EBITDA
- -0.10x
- Net debt / EBITDA
- 0.06x
Liquidity & coverage
- Current ratio
- 0.94x
- Quick ratio
- 0.94x
- Cash ratio
- 0.56x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- -$235.0K
Cash & dividend
- FCF / debt
- -8.82x
- Cash flow / debt
- -8.82x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026